FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
MAKO Surgical Corp. [ MAKO ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 06/08/2011 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 06/08/2011 | J(1) | 425,513(1) | D | $0.00 | 1,813,156 | I | By Montreux Equity Partners IV, L.P.(1) | ||
Common Stock | 06/09/2011 | S | 91,867 | D | $29.77(2) | 1,721,289 | I | By Montreux Equity Partners IV, L.P.(3) | ||
Common Stock | 06/09/2011 | S | 14,385 | D | $30.21(4) | 1,706,904 | I | By Montreux Equity Partners IV, L.P.(3) | ||
Common Stock | 06/08/2011 | J(5) | 2,701 | A | $0.00 | 5,420 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Montreux Equity Partners IV, L.P. distributed the shares to its general and limited partners on a pro rata basis. The reporting person is a managing member of Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. |
2. The sale price of the 91,867 shares reported on this Form 4 was between the range of $29.2317 per share and $30.1006 per share, with a weighted average sale price of $29.77 per share. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the Issuer upon request. |
3. The reported securities are owned directly by Montreux Equity Partners IV, L.P. The voting and disposition of the shares held by Montreux Equity Partners IV, L.P., is determined by Montreux Equity Management IV, LLC., the general partner of Montreux Equity Partners IV, L.P. The reporting person is a managing member of Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. |
4. The sale price of the 14,385 shares reported on this Form 4 was between the range of $30.11 per share and $30.40 per share, with a weighted average sale price of $30.21 per share. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the Issuer upon request. |
5. The reporting person received a pro rata distribution of the shares from Montreux Equity Management IV, LLC, to which he serves as managing member. Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P., received such shares as part of a pro rata distribution of the shares from Montreux Equity Partners IV, L.P. |
Remarks: |
/s/ Menashe R. Frank, attorney in fact | 06/10/2011 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |